1. Home
  2. TBBK vs VCEL Comparison

TBBK vs VCEL Comparison

Compare TBBK & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Bancorp Inc

TBBK

The Bancorp Inc

N/A

Current Price

$46.91

Market Cap

2.1B

Sector

Finance

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$40.12

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TBBK
VCEL
Founded
1999
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
TBBK
VCEL
Price
$46.91
$40.12
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
★ $76.00
$59.71
AVG Volume (30 Days)
414.4K
★ 519.3K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
14.69
★ 60.00
EPS
★ 2.86
N/A
Revenue
$141,147,000.00
★ $276,259,000.00
Revenue This Year
N/A
$21.71
Revenue Next Year
$0.56
$16.86
P/E Ratio
$17.69
★ N/A
Revenue Growth
★ 20.85
16.45
52 Week Low
$47.01
$28.95
52 Week High
$73.02
$49.32

Technical Indicators

Market Signals
Indicator
TBBK
VCEL
Relative Strength Index (RSI) 33.14 46.26
Support Level N/A $38.19
Resistance Level $51.47 $41.06
Average True Range (ATR) 1.47 1.57
MACD 0.26 0.06
Stochastic Oscillator 9.70 16.41

Price Performance

Historical Comparison
TBBK
VCEL

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: